Quick Answer
IGC Pharma, Inc. reported Shares Outstanding of 80.88 million shares for fiscal year 2025.
IGC Pharma, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 80.88M | +21.3% |
| 2024 | 66.69M | +25.6% |
| 2023 | 53.08M | +4.0% |
| 2022 | 51.05M | +6.7% |
| 2021 | 47.83M | +21.6% |
| 2020 | 39.32M | -0.5% |
| 2019 | 39.50M | +28.4% |
| 2018 | 30.76M | +8.8% |
| 2017 | 28.27M | +21.5% |
| 2016 | 23.27M | +57.6% |
| 2015 | 14.77M | +57.5% |
| 2014 | 9.37M | +34.3% |
| 2013 | 6.98M | +16.2% |
| 2012 | 6.01M | -59.7% |
| 2011 | 14.89M | +1046.4% |
| 2010 | 1.30M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 91.96M | +20.0% | +9.3% |
| June 30, 2025 | 84.14M | +11.2% | +4.0% |
| March 31, 2025 | 80.88M | +21.3% | +3.4% |
| December 31, 2024 | 78.20M | +22.7% | +2.0% |
| September 30, 2024 | 76.64M | +20.3% | +1.3% |
| June 30, 2024 | 75.64M | +42.5% | +13.4% |
| March 31, 2024 | 66.69M | +25.6% | +4.6% |
| December 31, 2023 | 63.73M | +20.1% | +0.0% |
- IGC Pharma, Inc. showed an increase of +21.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, IGC Pharma, Inc.’s shares outstanding has grown by 6126.6% (from 1.30 million shares to 80.88 million shares).
- The most recent figure is from IGC Pharma, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: